Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Amyloid burden and neural function in people at risk for Alzheimer's Disease.

Johnson SC, Christian BT, Okonkwo OC, Oh JM, Harding S, Xu G, Hillmer AT, Wooten DW, Murali D, Barnhart TE, Hall LT, Racine AM, Klunk WE, Mathis CA, Bendlin BB, Gallagher CL, Carlsson CM, Rowley HA, Hermann BP, Dowling NM, Asthana S, Sager MA.

Neurobiol Aging. 2014 Mar;35(3):576-84. doi: 10.1016/j.neurobiolaging.2013.09.028. Epub 2013 Oct 23.

PMID:
24269021
[PubMed - indexed for MEDLINE]
2.

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.

Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC.

Neuroimage Clin. 2014 Feb 19;4:604-14. doi: 10.1016/j.nicl.2014.02.001. eCollection 2014.

PMID:
24936411
[PubMed - in process]
Free PMC Article
3.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

PMID:
20935035
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ.

Brain. 2010 Feb;133(Pt 2):512-28. doi: 10.1093/brain/awp326. Epub 2010 Jan 15.

PMID:
20080878
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

Brain. 2012 Jul;135(Pt 7):2115-25. doi: 10.1093/brain/aws113. Epub 2012 May 3.

PMID:
22556189
[PubMed - indexed for MEDLINE]
Free Article
6.

Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.

Oh H, Habeck C, Madison C, Jagust W.

Hum Brain Mapp. 2014 Jan;35(1):297-308. doi: 10.1002/hbm.22173. Epub 2012 Sep 11.

PMID:
22965806
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.

Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.

Brain. 2011 Jan;134(Pt 1):301-17. doi: 10.1093/brain/awq349. Epub 2010 Dec 13.

PMID:
21149866
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.

Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative.

Brain. 2011 Apr;134(Pt 4):1077-88. doi: 10.1093/brain/awr044. Epub 2011 Mar 22.

PMID:
21429865
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.

Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):266-73. doi: 10.1136/jnnp-2013-305858. Epub 2013 Aug 21.

PMID:
23965289
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.

Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust WJ.

Neurobiol Aging. 2014 Aug;35(8):1873-82. doi: 10.1016/j.neurobiolaging.2014.02.015. Epub 2014 Feb 20.

PMID:
24656834
[PubMed - indexed for MEDLINE]
11.

Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.

Okada H, Ouchi Y, Ogawa M, Futatsubashi M, Saito Y, Yoshikawa E, Terada T, Oboshi Y, Tsukada H, Ueki T, Watanabe M, Yamashita T, Magata Y.

Brain. 2013 Oct;136(Pt 10):3004-17. doi: 10.1093/brain/awt195. Epub 2013 Aug 24.

PMID:
23975517
[PubMed - indexed for MEDLINE]
Free Article
12.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

PMID:
22628162
[PubMed - indexed for MEDLINE]
Free Article
13.

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, Nebes RD, Saxton JA, Snitz BE, Aizenstein HA, Wolk DA, Dekosky ST, Mathis CA, Klunk WE.

J Neurosci. 2009 Nov 25;29(47):14770-8. doi: 10.1523/JNEUROSCI.3669-09.2009.

PMID:
19940172
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Kreisl WC, Lyoo CH, McGwier M, Snow J, Jenko KJ, Kimura N, Corona W, Morse CL, Zoghbi SS, Pike VW, McMahon FJ, Turner RS, Innis RB; Biomarkers Consortium PET Radioligand Project Team.

Brain. 2013 Jul;136(Pt 7):2228-38. doi: 10.1093/brain/awt145. Epub 2013 Jun 17.

PMID:
23775979
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.

Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ.

Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6820-5. doi: 10.1073/pnas.0900345106. Epub 2009 Apr 3.

PMID:
19346482
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.

Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9.

PMID:
21310725
[PubMed - indexed for MEDLINE]
Free Article
17.

Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.

Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ.

JAMA Neurol. 2013 Dec;70(12):1512-9. doi: 10.1001/jamaneurol.2013.4013.

PMID:
24166579
[PubMed - indexed for MEDLINE]
18.

Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.

Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ.

J Neurosci. 2013 Mar 27;33(13):5553-63. doi: 10.1523/JNEUROSCI.4409-12.2013.

PMID:
23536070
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Association of gray matter atrophy with age, β-amyloid, and cognition in aging.

Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ.

Cereb Cortex. 2014 Jun;24(6):1609-18. doi: 10.1093/cercor/bht017. Epub 2013 Feb 6.

PMID:
23389995
[PubMed - indexed for MEDLINE]
20.

Amyloid-β and glucose metabolism in Alzheimer's disease.

Furst AJ, Lal RA.

J Alzheimers Dis. 2011;26 Suppl 3:105-16. doi: 10.3233/JAD-2011-0066.

PMID:
21971455
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk